Filing Details

Accession Number:
0001209191-21-024226
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 18:14:08
Reporting Period:
2021-03-30
Accepted Time:
2021-04-01 18:14:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1807120 Design Therapeutics Inc. DSGN Pharmaceutical Preparations (2834) 823929248
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1849216 Justin Thacker C/o Design Therapeutics, Inc.
6005 Hidden Valley Road, Suite 110
Carlsbad CA 92011
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-30 17,500 $20.00 17,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares were purchased in the Issuer's initial public offering.